---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-013433"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2025-06-03T23:59:59+00:00"
generated_at: "2026-05-20T01:18:36.739894+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# InspireMD appoints Michael Lawless as CFO, succeeding Craig Shore

## Summary
- Michael Lawless appointed CFO effective on/before June 30, 2025; succeeds Craig Shore who served ~15 years.
- Base salary of $375,000 annually, plus performance bonus up to 50% of base salary.
- Inducement grant: 212,000 stock options and 465,000 restricted shares, vesting over 3 years under NASDAQ Rule 5635(c)(4).
- Employment agreement has 3-year initial term with automatic renewal; severance includes 6 months base salary (non-CIC) or 12 months (CIC).
- Lawless previously CFO of Lifeward (LFWD) and held senior finance roles at Azenta, PerkinElmer, and Momenta Pharmaceuticals.

## SEC filing metadata
- accession: 0001641172-25-013433
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2025-06-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000164117225013433/0001641172-25-013433-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000164117225013433/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-013433
- JSON: https://secwatch.observer/filing/0001641172-25-013433.json
- Plain text: https://secwatch.observer/filing/0001641172-25-013433.txt

## Key facts
- Executive change
  Michael Lawless was appointed as Chief Financial Officer at InspireMD, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On June 2, 2025, InspireMD, Inc. (the “ Company ”) appointed Michael Lawless as Chief Financial Officer of the Company, effective on or before June 30, 2025 (the “ Effective Date ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1433607/000164117225013433/0001641172-25-013433-index.htm
- Executive change
  Craig Shore was terminated as Chief Financial Officer at InspireMD, Inc..
  - Action: terminated
  - Role: Chief Financial Officer
  source text: On the Effective Date, Mr. Lawless will succeed Craig Shore, whose employment as the Company’s Chief Financial Officer will be terminated simultaneous with Mr. Lawless’s appointment.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1433607/000164117225013433/0001641172-25-013433-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.